Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene <i>DAB2</i> as a Prognostic Biomarker in Differentiated Thyroid Carcinoma.

Authors:
Ju G; Zhang L; Guo W; Wang H; Zhang X and 9 more

Journal:
Dis Markers

Publication Year: 2022

DOI:
10.1155/2022/1686316

PMCID:
PMC10202610

PMID:
37223105

Journal Information

Full Title: Dis Markers

Abbreviation: Dis Markers

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest There are no competing interests declared for all authors."

Evidence found in paper:

"This study is supported by National Natural Science Foundation of China (No. 81771875), CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2016-I2M-2-006), the Non profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2019XK320009), the CSCO-Hengrui Research Foundation (No. Y-HR2018-143, Y-HR2018-144), and Project on InterGovernmental International Scientific and Technological Innovation Cooperation in National Key Projects of Research and Development Plan (No. 2019YFE0106400)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025